Fundamental dimension Equity attribute | ANPeer $161.05▼-0.49% Cap $5.32BP/E 7.3x QuantScore39/100 | ABGLeader $172.65▼-0.45% Cap $3.10BP/E 6.4x QuantScore52/100 | ALSNPeer $106.32▼-2.97% Cap $8.78BP/E 16.8x QuantScore42/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical Trend, RSI, MACD & signal consensus | |||
49/100 |
57/100 |
23/100 |
Valuation Multiples, PEG & DCF upside | 79/100 | 100/100 | 76/100 |
Health Piotroski, Altman Z, leverage & liquidity | 12/100 | 22/100 | 26/100 |
Growth Revenue / earnings growth & margins | 5/100 | 16/100 | 30/100 |
Sentiment Analyst ratings, targets & revisions | 48/100 | 65/100 | 53/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 7.3x | 6.4x | 16.8x |
Forward P/E (next FY) | 7.7x | 6.8x | 13.1x |
EV / EBITDA (TTM) | 10.1x | 8.1x | 11.4x |
Price / Sales | 0.2x | 0.2x | 2.4x |
Price / Free Cash Flow | 440.0x | 6.2x | 12.0x |
PEG ratio | 0.21 | -2.57 | -0.58 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 4 / 9 | 5 / 9 | 5 / 9 |
Altman Z-Score | 2.78 (Grey) | 2.52 (Grey) | 1.70 (Distress) |
Total debt / equity | 5.02 | 1.41 | 2.08 |
Quick ratio | 0.2x | 0.3x | 1.2x |
Interest coverage | 2.9x | 3.1x | 5.6x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +3.2% | +4.7% | -6.7% |
Net income growth YoY | -6.2% | +14.3% | -14.8% |
Gross margin (TTM) | 17.8% | 17.1% | 39.5% |
Operating margin (FY) | 4.7% | 5.6% | 32.3% |
FCF margin (FY) | -0.7% | 3.2% | 21.6% |
5. Trailing price performancePrice change over period |
1M return | -1.1% | -4.1% | -5.7% |
3M return | -22.6% | -23.3% | -13.1% |
6M return | -20.7% | -15.0% | -21.5% |
Year to date | -22.0% | -25.8% | +8.6% |
1Y return | -19.6% | -27.9% | +28.4% |
3Y return | +24.5% | -7.4% | +85.1% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $400.81 +148.9% upside | $603.44 +249.5% upside | $83.46 -21.5% premium |
Wall Street consensus target | $223.00 +38.5% · range $175.00–$255.00 | $235.50 +36.4% · range $184.00–$300.00 | $127.00 +19.5% · range $120.00–$135.00 |
Consensus stance | 59% Buy35% Hold6% Sell | 32% Buy63% Hold5% Sell | 28% Buy52% Hold21% Sell |